Skip to content

Clinical trials

Non-alcoholic Fatty Liver Disease trials in Hungary

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Non-alcoholic Fatty Liver Disease Country / region: Hungary Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20161
20172
20182
20191
20213
20232
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting3
Unknown status3
Active, not recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Intercept Pharmaceuticals2
University of Pecs2
89bio, Inc.1
Boehringer Ingelheim1
Bristol-Myers Squibb1
Eli Lilly and Company1
Future Medicine1
Inventiva Pharma1
Madrigal Pharmaceuticals, Inc.1
Merck Sharp & Dohme LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Non-alcoholic Fatty Liver Disease15
Fibrosis3
Diabetes Mellitus2
Fatty Liver2
Liver Diseases2
Renal Insufficiency, Chronic2
Aortic Coarctation1
Aortic Valve Stenosis1
Diabetes Complications1
Diabetes Mellitus, Type 11

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.